Inventor · disambiguated record
Barbara A. Swanson
Also filed as: SWANSON BARBARA · SWANSON BARBARA A · SWANSON BARBARA ANNE
31 granted patents·12 pending applications·452 citations·filing 1996–2021
97Inventor score
Top patents by PatentIndex Score
43 records- 0197US10058609B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·17 cites·14 claims
- 0297US7744874B2Anti-sclerostin antibodiesLILLY CO ELI·Filed 2008·Granted Jun 29, 2010·55 cites·10 claims
- 0396US9175082B2Antigen binding proteins that bind PD-L1ZHOU HEYUE·Filed 2013·Granted Nov 3, 2015·178 cites·5 claims
- 0492US9676853B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·15 cites·20 claims
- 0591US10377827B2Antigen binding proteins that bind c-metSORRENTO THERAPEUTICS INC·Filed 2013·Granted Aug 13, 2019·14 cites·6 claims
- 0690US6599722B2Method for producing ascorbic acid intermediatesGENENCOR INT·Filed 1998·Granted Jul 29, 2003·42 cites·24 claims
- 0789US10035855B2Antibody therapeutics that bind CD47SORRENTO THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·8 cites·15 claims
- 0889US7820163B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2008·Granted Oct 26, 2010·11 cites·9 claims
- 0986US6451063B1Cellulase for use in industrial processesGENENCOR INT·Filed 1996·Granted Sep 17, 2002·45 cites·11 claims
- 1085US8148498B2DKK-1 antibodiesCHEDID MARCIO·Filed 2010·Granted Apr 3, 2012·14 cites·14 claims
- 1179US9315579B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 19, 2016·3 cites·8 claims
- 1278US10435476B2Antibody therapeutics that bind JAG1SORRENTO THERAPEUTICS INC·Filed 2016·Granted Oct 8, 2019·4 cites·5 claims
- 1377US11878058B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·19 claims
- 1477US10584168B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·1 cites·7 claims
- 1575US8765129B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2012·Granted Jul 1, 2014·2 cites·5 claims
- 1675US7988970B2Methods of treatment comprising administering an anti-sclerostin antibodyLILLY CO ELI·Filed 2010·Granted Aug 2, 2011·2 cites·2 claims
- 1774US8329174B2Anti-hepcidin antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2010·Granted Dec 11, 2012·2 cites·9 claims
- 1874US2022242954A1Antigen Binding Proteins that Bind PD-1SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1971US11155628B2Antigen binding proteins that bind c-MetSORRENTO THERAPEUTICS INC·Filed 2019·Granted Oct 26, 2021·0 cites·18 claims
- 2071US10668148B2Fully human anti-C-X-C chemokine receptor 3 (CXCR3) antibodies and methods of use thereofSORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 2, 2020·0 cites·14 claims
- 2171US6967246B2Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swolleninsGENENCOR INT·Filed 2002·Granted Nov 22, 2005·4 cites·14 claims
- 2270US9765146B2Fully human anti-CXC chemokine receptor 5 (CXCR5) antibodiesSORRENTO THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·1 cites·19 claims
- 2369US11242391B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·0 cites·7 claims
- 2469US11027012B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 8, 2021·0 cites·10 claims
- 2569US9944707B2Antibodies that bind epidermal growth factor receptor (EGFR)SORRENTO THERAPEUTICS INC·Filed 2013·Granted Apr 17, 2018·1 cites·16 claims
- 2669US2022002422A1Antigen Binding Proteins that Bind c-MetSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2764US6080568AMutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformisGENENCOR INT·Filed 1997·Granted Jun 27, 2000·28 cites·11 claims
- 2862US10696746B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 30, 2020·0 cites·5 claims
- 2960US2017182161A1Antigen Binding Proteins that Bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3058US2004180413A1Method for producing ascorbic acid intermediatesFiled 2003·Application pending·0 cites
- 3157US2005227337A1Method for producing ascorbic acid intermediatesBOSTON MATTHEW G·Filed 2003·Application pending·0 cites
- 3255US2023147852A1Engineered Antibodies That Bind LAG3SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3354US9951138B2Antigen binding proteins that bind CCR2SORRENTO THERAPEUTICS INC·Filed 2016·Granted Apr 24, 2018·0 cites·20 claims
- 3453US10479837B2Methods for treating subjects having a CXC chemokine receptor 5 (CXCR5)-responsive cancer by administering fully human anti-CXCR5 antibodiesSORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 19, 2019·0 cites·5 claims
- 3553US9765145B2Fully human anti-C-X-C chemokine receptor 3 (CXCR5) antibodiesSORRENTO THERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·0 cites·11 claims
- 3653US2019008955A1Fully human anti-c-x-c chemokine receptor 3 (cxcr3) antibodiesSORRENTO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3752US2023235059A1Anti-pd1 antibodies and uses thereofSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3852US2002193272A1Cellulase for use in industrial processesFiled 2002·Application pending·0 cites
- 3950US8257704B2Anti-sclerostin antibodiesKORYTKO ANDREW IHOR·Filed 2011·Granted Sep 4, 2012·0 cites·2 claims
- 4050US2022363758A1Heterodimeric Antibodies That Bind to CD38 and CD3SORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4150US2022144966A1Engineered Variant Antibodies that Bind CD38SORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4240US6458928B1Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swolleninsGENENCOR INT·Filed 1998·Granted Oct 1, 2002·5 cites·6 claims
- 4335US2002177198A1Method for producing ascorbic acid intermediatesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Barbara A. Swanson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →